A randomized phase III trial of gemcitabine (G) in combination with carboplatin (C) or paclitaxel (P) versus paclitaxel plus carboplatin in advanced (Stage IIIB, IV) non-small cell lung cancer (NSCLC): Update of the Alpha Oncology trial (A1-99002L).

被引：0
|
作者：
Treat, J
Belani, CP
Edelman, MJ
Socinski, MA
Ansari, RH
Obasaju, CK
Bloss, JD
Marinucci, DM
Catalano, RB
Comis, RL
机构：
[1] Fox Chase Temple Canc Ctr, Philadelphia, PA USA
[2] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA
[3] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA
[4] Univ N Carolina, Chapel Hill, NC USA
[5] Michana Hematol Oncol PC, South Bend, IN USA
[6] Lilli Oncol, Indianapolis, IN USA
[7] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1096S / 1096S
页数：1
相关论文
共 50 条
  • [21] Pemetrexed plus carboplatin versus gemcitabine plus carboplatin in the treatment of stage IIIB/IV non-small cell lung cancer
    Gronberg, B. H.
    Bremnes, R.
    Aasebo, U.
    Brunsvig, P.
    Flotten, O.
    Hjelde, H.
    Wammer, F.
    Stornes, F.
    Tollali, T.
    Sundstrom, S. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [22] Incidence and outcomes associated with brain metastases (BM) in a three-arm phase III trial of gemcitabine in combination with carboplatin (GC) or paclitaxel (GP) versus paclitaxel plus carboplatin (PC) for advanced non-small cell lung cancer (NSCLC)
    Edelman, M. J.
    Belani, C. P.
    Socinski, M. A.
    Ansari, R.
    Obasaju, C. K.
    Monberg, M. J.
    Chen, R.
    Treat, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [23] Phase II randomized trial of vinorelbine and gemcitabine versus carboplatin and paclitaxel in advanced non-small-cell lung cancer
    Lilenbaum, RC
    Chen, CS
    Chidiac, T
    Schwarzenberger, PO
    Thant, M
    Versola, N
    Lane, SR
    ANNALS OF ONCOLOGY, 2005, 16 (01) : 97 - 101
  • [24] Combination chemotherapy with paclitaxel plus carboplatin versus paclitaxel plus gemcitabine in inoperable non-small cell lung cancer: A phase III randomized study. Preliminary results
    Kosmidis, P
    Mylonakis, N
    Dimopoulos, A
    Pavlidis, N
    Fountzilas, G
    Samantas, E
    Dimitriadis, K
    Kalophonos, C
    Tsavdaridis, D
    Skarlos, D
    SEMINARS IN ONCOLOGY, 2000, 27 (01) : 3 - 8
  • [25] Randomized, Phase III Trial of First-Line Figitumumab in Combination With Paclitaxel and Carboplatin Versus Paclitaxel and Carboplatin Alone in Patients With Advanced Non-Small-Cell Lung Cancer
    Langer, Corey J.
    Novello, Silvia
    Park, Keunchil
    Krzakowski, Maciej
    Karp, Daniel D.
    Mok, Tony
    Benner, Rebecca J.
    Scranton, Judith R.
    Olszanski, Anthony J.
    Jassem, Jacek
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (19) : 2059 - U109
  • [26] Phase II trial of carboplatin plus cetuximab for the treatment of stage IIIB/IV non-small cell lung cancer (NSCLC)
    Bradford, D. S.
    Socinski, M. A.
    LaRocca, R. V.
    Hensing, T. A.
    Bordoni, R. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [27] Phase II trial with carboplatin/gemcitabine induction chemotherapy followed by radiotherapy concomitantly with paclitaxel/gemcitabine in stage III non-small cell lung cancer (NSCLC).
    Hirsh, V.
    Duclos, M.
    Souhami, L.
    Del Vecchio, P.
    Ofiara, L.
    Faria, S.
    Ayoub, J.
    Charpentier, D.
    Portelance, L.
    Soulieres, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 398S - 398S
  • [28] A randomized, phase II trial of two dose schedules of carboplatin/paclitaxel/cetuximab in stage IIIB/IV non-small-cell lung cancer (NSCLC)
    Socinski, M. A.
    Saleh, M. N.
    Trent, D. F.
    Dobbs, T. W.
    Zehngebot, L. M.
    Levine, M. A.
    Bordoni, R.
    Stella, P. J.
    ANNALS OF ONCOLOGY, 2009, 20 (06) : 1068 - 1073
  • [29] Paclitaxel/gemcitabine versus paclitaxel/vinorelbine in advanced non-small cell lung cancer (NSCLC): A phase III randomized study
    Kosmidis, P. A.
    Timotheadou, E.
    Koutras, A.
    Pentheroudakis, G.
    Christodoulou, C.
    Dimopoulos, A. M.
    Bafaloukos, D.
    Samantas, E.
    Pectasides, D.
    Syrigos, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [30] A Phase I trial of paclitaxel plus carboplatin in untreated patients with advanced non-small cell lung cancer
    Kelly, K
    Pan, ZX
    Murphy, J
    Huffman, DH
    Bunn, PA
    CLINICAL CANCER RESEARCH, 1997, 3 (07) : 1117 - 1123
12345